These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 2150818)

  • 21. Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors.
    Callahan PM; Cunningham KA
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1414-24. PubMed ID: 7562516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibitory effect of trifluoromethylphenylpiperazine on [3H]acetylcholine release in guinea pig hippocampal synaptosomes is mediated by a 5-hydroxytryptamine1 receptor distinct from 1A, 1B, and 1C subtypes.
    Harel-Dupas C; Cloëz I; Fillion G
    J Neurochem; 1991 Jan; 56(1):221-7. PubMed ID: 1824781
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).
    Glennon RA
    Pharmacol Biochem Behav; 1986 Jul; 25(1):135-9. PubMed ID: 2944129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT1A, 5-HT1B and 5-HT2 receptor agonists induce differential behavioral responses in preweanling rat pups.
    Frambes NA; Kirstein CL; Moody CA; Spear LP
    Eur J Pharmacol; 1990 Jun; 182(1):9-17. PubMed ID: 2144825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 5-HT2 receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)2-aminopropane increases brain tryptophan levels in the rat.
    Chaouloff F; Baudrie V; Layeillon C; Broqua P
    Eur J Pharmacol; 1992 Apr; 214(1):101-3. PubMed ID: 1533838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuation of 5-HT1A and 5-HT2 but not 5-HT1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants.
    Berendsen HH; Broekkamp CL
    Psychopharmacology (Berl); 1991; 105(2):219-24. PubMed ID: 1839064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noradrenergic mediation of spinal antinociception by 5-hydroxytryptamine: characterization of receptor subtypes.
    Sawynok J; Reid A
    Eur J Pharmacol; 1992 Nov; 223(1):49-56. PubMed ID: 1362158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of the 5-HT1C receptor-mediated behavior by 5-HT2, but not 5-HT1A, receptor activation.
    Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1992; 44(5):427-36. PubMed ID: 1363616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic investigation of the stimulus properties of 1-(3-trifluoromethylphenyl)piperazine.
    Herndon JL; Pierson ME; Glennon RA
    Pharmacol Biochem Behav; 1992 Nov; 43(3):739-48. PubMed ID: 1333084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons.
    Sprouse JS; Aghajanian GK
    Neuropharmacology; 1988 Jul; 27(7):707-15. PubMed ID: 2901680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5-HT1A receptors and the tail-flick response. V. Opposite modulation of 5-HT1A receptor-induced spontaneous tail-flicks by alpha 1A- as compared with alpha 2D-adrenoceptors in rat lumbar spinal cord.
    Bervoets K; Millan MJ
    J Pharmacol Exp Ther; 1994 Apr; 269(1):110-20. PubMed ID: 7909554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
    Przegaliński E; Budziszewska B; Warchoł-Kania A; Błaszczyńska E
    Pharmacol Biochem Behav; 1989 Jun; 33(2):329-34. PubMed ID: 2530590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do functional relationships exist between 5-HT1A and 5-HT2 receptors?
    Darmani NA; Martin BR; Pandey U; Glennon RA
    Pharmacol Biochem Behav; 1990 Aug; 36(4):901-6. PubMed ID: 2145593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat.
    Bagdy G; Kalogeras KT
    Brain Res; 1993 May; 611(2):330-2. PubMed ID: 8334526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the effects of activation of ventral medullary serotonin receptor subtypes on cardiovascular activity and respiratory motor outflow to the diaphragm and larynx.
    King KA; Holtman JR
    J Pharmacol Exp Ther; 1990 Feb; 252(2):665-74. PubMed ID: 2138222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.